Drug offers relief for symptoms of myelofibrosis
People with a blood cancer myelofibrosis can benefit from a drug called ruxolitinib, according to a randomized, double-blind, placebo-controlled clinical trial that included patients and researchers from the ...
Feb 29, 2012
0
0